Sugino Kiminori, Kameyama Kaori, Nagahama Mitsuji, Kitagawa Wataru, Shibuya Hiroshi, Ohkuwa Keiko, Uruno Takashi, Akaishi Junko, Suzuki Akifumi, Masaki Chie, Matsuzu Kenichi, Kawano Michikazu, Ito Koichi
Department of Surgery, Ito Hospital, Tokyo 150-8308, Japan.
Endocr J. 2014;61(3):273-9. doi: 10.1507/endocrj.ej13-0437. Epub 2014 Jan 10.
Follicular thyroid carcinoma (FTC) usually has a good prognosis unless there is distant metastasis (DM). In this retrospective study we evaluated the outcome of FTC patients with DM and attempted to identify prognostic factors. The subjects of this study were the 106 of FTC patients who underwent thyroidectomy at our hospital between 1989 and 2010 who had been diagnosed with DM at presentation or had developed DM after the initial surgery. Their cumulative cause-specific survival (CSS) rate from diagnosis of DM to date of last follow-up was calculated by the Kaplan-Meier method. Prognostic factors were identified by univariate analysis (the log-rank test) and multivariate analysis (Cox's proportional hazards model). The site of the DM was the lung in 36 patients, bone in 33 patients, both lung and bone in 28 patients and other sites in 9 patients. During the follow-up period, 22 patients died of their disease. The DMs were treated by radioactive iodine (RI) therapy in 80 patients, by surgical treatment in 36 patients and by external beam radiation therapy (EBRT) in 27 patients. The CSS rates at 5, 10, and 15 years after the first DM was diagnosed were 82.2%, 63.8%, and 23.9%, respectively. Univariate analyses and multivariate analysis identified age at diagnosis of DM and primary tumor size as significant factors related to CSS. In this study, we could not show RI therapy, EBRT or surgical treatment for DM had an impact on the outcome.
滤泡状甲状腺癌(FTC)通常预后良好,除非发生远处转移(DM)。在这项回顾性研究中,我们评估了发生DM的FTC患者的预后情况,并试图确定预后因素。本研究的对象是1989年至2010年间在我院接受甲状腺切除术的106例FTC患者,这些患者在就诊时被诊断为DM或在初次手术后发生DM。采用Kaplan-Meier法计算从DM诊断至最后一次随访日期的累积特定病因生存率(CSS)。通过单因素分析(对数秩检验)和多因素分析(Cox比例风险模型)确定预后因素。DM的部位为肺36例,骨33例,肺和骨均受累28例,其他部位9例。随访期间,22例患者死于该病。80例患者采用放射性碘(RI)治疗DM,36例采用手术治疗,27例采用外照射放疗(EBRT)。首次诊断DM后5年、10年和15年的CSS率分别为82.2%、63.8%和23.9%。单因素分析和多因素分析确定DM诊断时的年龄和原发肿瘤大小是与CSS相关的重要因素。在本研究中,我们未能显示针对DM的RI治疗、EBRT或手术治疗对预后有影响。